PLoS ONEGeneticsPeer-reviewed journal article
The zebrafish orthologue of familial Alzheimer’s disease gene PRESENILIN 2 is required for normal adult melanotic skin pigmentation
Abstract
Alzheimers disease is the most common form of age-related dementia. At least 15 mutations in the human gene PRESENILIN 2 (PSEN2) have been found to cause familial Alzheimers disease (fAD). Zebrafish possess an orthologous gene, psen2, and present opportunities for investigation of PRESENILIN function related to Alzheimers disease. The most prevalent and best characterized fAD mutation in PSEN2 is N141I. The equivalent codon in zebrafish psen2 is N140. We used genome editing technology in zebrafish to target generation of mutations to the N140 codon. We isolated two mutations: psen2N140fs, (hereafter \"N140fs\"), causing truncation of the coding sequence, and psen2T141_L142delinsMISLISV, (hereafter \"T141_L142delinsMISLISV\"), that deletes the two codons immediately downstream of N140 and replaces them with seven codons coding for amino acid residues MISLISV. Thus, like almost every fAD mutation in the PRESENILIN genes, this latter mutation does not truncate the genes open reading frame. Both mutations are homozygous viable although N140fs transcripts are subject to nonsense-mediated decay and lack any possibility of coding for an active {gamma}-secretase enzyme. N140fs homozygous larvae initially show grossly normal melanotic skin pigmentation but subsequently lose this as they grow while retaining pigmentation in the retinal pigmented epithelium. T141_L142delinsMISLISV homozygotes retain faint skin melanotic pigmentation as adults, most likely indicating that the protein encoded by this allele retains weak {gamma}-secretase activity. Null mutations in the human PRESENILIN genes do not cause Alzheimers disease so these two mutations may be useful for future investigation of the differential effects of null and fAD-like PRESENILIN mutations on brain aging.\n\nFinancial Disclosure StatementThis research was supported by grants from the National Health and Medical Research Council of Australia, GNT1061006 and GNT1126422, and by funds from the School of Biological Sciences of the University of Adelaide. HJ is supported by an Adelaide Scholarship International from the University of Adelaide.\n\nConflict of Interest StatementThe authors declare no conflict of interest.
- Citations
- 36
- FWCI
- 3.77
- Field percentile
- top 6%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Frameshift and frame-preserving mutations in zebrafish presenilin 2 affect different cellular functions in young adult brains
Karissa Barthelson, Stephen Pederson, … Michael T. Lardelli·Journal of Alzheimer s Disease ReportsPeer-reviewed·Mar 11, 2021
- Transcriptome analysis indicates dominant effects on ribosome and mitochondrial function of a premature termination codon mutation in the zebrafish gene psen2
Haowei Jiang, Stephen Pederson, … Michael T. Lardelli·PLoS ONEPeer-reviewed·Jul 13, 2020
- PRESENILIN 1 mutations causing early-onset familial Alzheimer's disease or familial acne inversa differ in their effects on genes facilitating energy metabolism and signal transduction
Karissa Barthelson, Yang Dong, … Michael T. Lardelli·Journal of Alzheimer s DiseasePeer-reviewed·May 21, 2021
- A familial Alzheimer's disease-like mutation in the zebrafish presenilin 1 gene affects brain energy production
Morgan Newman, Nhi Hin, … Michael T. Lardelli·Molecular BrainPeer-reviewed·May 3, 2019
- Accelerated brain aging towards transcriptional inversion in a zebrafish model of familial Alzheimer’s disease
Nhi Hin, Morgan Newman, … Michael T. Lardelli·PLoS ONEPeer-reviewed·Jan 24, 2020
- Transcriptome analyses of 7-day-old zebrafish larvae possessing a familial Alzheimer's disease-like mutation in psen1 indicate effects on oxidative phosphorylation, mcm functions, and iron homeostasis
Yang Dong, Morgan Newman, … Michael T. Lardelli·BMC GenomicsPeer-reviewed·Mar 24, 2021